Sperl, J. Et Al. 2016. C-EDGE HEAD-TO-HEAD: EFFICACYAND SAFETY OF ELBASVIR AND GRAZOPREVIR COMPARED WITH SOFOSBUVIR/PEGYLATED INTERFERON/RIBAVIRIN: A PHASE 3 RANDOMIZED CONTROLLED TRIAL. EASL International Liver Congress , (Barcelona, Spain).

Sperl, J., Horvath, G., Halota, W., Ruiz-Tapiador, J. A., Streinu-Cercel, A., Jancoriene, L., ... Werling, K.(2016). C-EDGE HEAD-TO-HEAD: EFFICACYAND SAFETY OF ELBASVIR AND GRAZOPREVIR COMPARED WITH SOFOSBUVIR/PEGYLATED INTERFERON/RIBAVIRIN: A PHASE 3 RANDOMIZED CONTROLLED TRIAL . EASL International Liver Congress, Barcelona, Spain

Sperl, J. Et Al. "C-EDGE HEAD-TO-HEAD: EFFICACYAND SAFETY OF ELBASVIR AND GRAZOPREVIR COMPARED WITH SOFOSBUVIR/PEGYLATED INTERFERON/RIBAVIRIN: A PHASE 3 RANDOMIZED CONTROLLED TRIAL," EASL International Liver Congress, Barcelona, Spain, 2016

Sperl, J. Et Al. "C-EDGE HEAD-TO-HEAD: EFFICACYAND SAFETY OF ELBASVIR AND GRAZOPREVIR COMPARED WITH SOFOSBUVIR/PEGYLATED INTERFERON/RIBAVIRIN: A PHASE 3 RANDOMIZED CONTROLLED TRIAL." EASL International Liver Congress , Barcelona, Spain, 2016

Sperl, J. Et Al. (2016) . "C-EDGE HEAD-TO-HEAD: EFFICACYAND SAFETY OF ELBASVIR AND GRAZOPREVIR COMPARED WITH SOFOSBUVIR/PEGYLATED INTERFERON/RIBAVIRIN: A PHASE 3 RANDOMIZED CONTROLLED TRIAL." EASL International Liver Congress , Barcelona, Spain.

@conferencepaper{conferencepaper, author={J. Sperl Et Al. }, title={C-EDGE HEAD-TO-HEAD: EFFICACYAND SAFETY OF ELBASVIR AND GRAZOPREVIR COMPARED WITH SOFOSBUVIR/PEGYLATED INTERFERON/RIBAVIRIN: A PHASE 3 RANDOMIZED CONTROLLED TRIAL}, congress name={EASL International Liver Congress}, city={Barcelona}, country={Spain}, year={2016}}